Abstract

Tankyrase enzymes (TNKS), a core part of the canonical Wnt pathway, are a promising target in the search for potential anti-cancer agents. Although several hundreds of the TNKS inhibitors are currently known, identification of their novel chemotypes attracts considerable interest. In this study, the molecular docking and machine learning-based virtual screening techniques combined with the physico-chemical and ADMET (absorption, distribution, metabolism, excretion, toxicity) profile prediction and molecular dynamics simulations were applied to a subset of the ZINC database containing about 1.7 M commercially available compounds. Out of seven candidate compounds biologically evaluated in vitro for their inhibition of the TNKS2 enzyme using immunochemical assay, two compounds have shown a decent level of inhibitory activity with the IC50 values of less than 10 nM and 10 μM. Relatively simple scores based on molecular docking or MM-PBSA (molecular mechanics, Poisson-Boltzmann, surface area) methods proved unsuitable for predicting the effect of structural modification or for accurate ranking of the compounds based on their binding energies. On the other hand, the molecular dynamics simulations and Free Energy Perturbation (FEP) calculations allowed us to further decipher the structure-activity relationships and retrospectively analyze the docking-based virtual screening performance. This approach can be applied at the subsequent lead optimization stages.

Highlights

  • The tankyrase enzymes (TNKS1 and TNKS2, known as PARP5a and PARP5b) belong to the poly(ADP-ribose) polymerase (PARP) superfamily

  • Note: a ∆G values relative to the compound A1 are listed in parentheses. These results suggest a better explanation of the observed difference in the inhibitory activity of the compounds A1 and A3 compared to the MM-PBSA method

  • That could be related to the explicit accounting for the solvation effects, in contrast to the docking-based methods or continuum solvation models used by the MM-PBSA approach

Read more

Summary

Introduction

The tankyrase enzymes (TNKS1 and TNKS2, known as PARP5a and PARP5b) belong to the poly(ADP-ribose) polymerase (PARP) superfamily. They play vital roles in mitosis control, telomere maintenance and regulation of the canonical Wnt pathway [1]. Molecules 2020, 25, 3171 is often associated with various cancers [2], TNKS enzymes are considered potential pharmacological targets for anti-tumor agents. The efforts aimed at using tankyrase inhibitors in combination with other drugs are worth noting. Multitarget inhibitors able to act on the previously mentioned kinases and the TNKS enzymes could be beneficial thanks to diminished xenobiotic load It is believed that the synergistic effect could occur when tankyrase is inhibited simultaneously with cyclin-dependent kinases 4 and 6 [3] or phosphoinositide 3-kinase [4].

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.